marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 03-03-2025
TG Therapeutics Financial Ratios 2011-2025 | TGTX
Annual Financial Ratios TG Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
209.7 | 191.2 | -9.1 | -4.4 | -19.9 | -7.3 | -1.9 | -6.1 | -2.9 | -5.9 | -8.7 | -7.6 | -2.6 | -2.3 |
P/S |
14.9 | 10.4 | 734.7 | 228.7 | 36626.0 | 8284.6 | 2149.8 | 4765.8 | 1512.6 | 2447.4 | 3183.7 | 1024.0 | 2512.9 | - |
EPS |
0.2 | 0.1 | -1.6 | -2.6 | -2.4 | -2.0 | -2.3 | -1.9 | -1.6 | -1.4 | -1.6 | -0.8 | -1.4 | -0.4 |
EV (Enterprise Value) |
5.08 B | 2.5 B | 2.08 B | 1.37 B | 5.12 B | 1.27 B | 344 M | 700 M | 224 M | 330 M | 436 M | 124 M | 37.9 M | -1.53 M |
EBITDA per Share |
0.29 | 0.15 | -1.61 | -2.61 | -2.37 | -1.91 | -2.31 | -1.91 | -1.61 | -1.38 | -1.64 | -0.794 | -1.97 | -0.458 |
EV/EBITDA |
-3.8 | -18.5 | -7.0 | -1.6 | -5.6 | -2.6 | -5.0 | -7.7 | -5.8 | -1.3 | 3.3 | |||
PEG |
-52.23 | -7.31 | 82.18 | -0.39 | -1.59 | -0.49 | 0.09 | 0.32 | 0.18 | -0.37 | 0.08 | -0.18 | 0.01 | 0.03 |
P/B |
22.1 | 15.1 | 34.9 | 6.5 | 10.7 | 32.6 | 13.6 | 10.8 | 6.4 | 3.7 | 6.1 | 3.9 | 3.1 | 0.2 |
P/CF |
-121.0 | -77.1 | -11.6 | -5.2 | -26.0 | -9.5 | -2.5 | -7.7 | -3.7 | -8.3 | -13.8 | -14.4 | -9.2 | -22.5 |
ROE % |
10.52 | 7.90 | -382.02 | -146.78 | -53.79 | -447.68 | -721.76 | -176.85 | -218.17 | -61.97 | -69.64 | -51.13 | -116.22 | -8.86 |
ROA % |
4.05 | 3.84 | -115.62 | -91.70 | -44.66 | -106.05 | -207.47 | -121.66 | -142.85 | -55.47 | -64.30 | -42.56 | -81.87 | -5.36 |
ROCE % |
18.86 | 12.86 | -372.64 | -145.38 | -52.68 | -215.18 | -389.62 | -170.99 | -208.34 | -61.37 | -68.26 | -48.26 | -129.87 | -6.22 |
Current Ratio |
1.6 | 1.9 | 1.4 | 2.7 | 5.9 | 1.8 | 2.0 | 3.3 | 3.0 | 8.3 | 16.6 | 6.7 | 8.3 | 6.1 |
DSO |
100.0 | - | - | 37.9 | - | - | 228.1 | 259.8 | 200.9 | 445.6 | 204.8 | 65.1 | - | - |
DIO |
712.6 | 514.3 | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
812.6 | 514.3 | - | 37.9 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
812.6 | 514.3 | - | 37.9 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios TG Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.03 | 0.05 | -0.07 | - | 0.8 | -0.34 | -0.28 | - | -0.26 | -0.3 | -0.51 | - | -0.65 | -0.59 | -0.69 | - | -0.73 | -0.47 | -0.48 | -0.44 | -0.69 | -0.42 | -0.43 | -0.68 | -0.43 | -0.59 | -0.59 | -0.46 | -0.48 | -0.45 | -0.52 | -0.48 | -0.5 | -0.33 | -0.28 | -0.37 | -0.28 | -0.38 | -0.35 | -0.48 | -0.51 | -0.36 | -0.25 | - | -0.16 | -0.29 | -0.17 | - | -0.16 | -0.16 | -2.03 | - | -0.01 | -0.15 | - |
EBITDA per Share |
- | - | -0.06 | - | - | - | -0.26 | - | -0.26 | -0.29 | -0.5 | - | -0.64 | -0.59 | -0.68 | - | -0.72 | -0.45 | -0.48 | - | -0.68 | -0.41 | -0.43 | - | -0.44 | 0.6 | -0.59 | - | -0.48 | -0.45 | -0.52 | - | -0.51 | -0.33 | -0.29 | - | -0.29 | -0.38 | -0.36 | - | -0.51 | -0.36 | -0.25 | - | -0.17 | -0.29 | -0.17 | - | -0.17 | -0.26 | -3.43 | - | -0.01 | -0.16 | - |
ROE % |
68.35 | 135.48 | 13.91 | -191.56 | -227.20 | -332.00 | -245.70 | -107.55 | -135.04 | -126.88 | -115.97 | -68.33 | -85.11 | -74.41 | -64.10 | -36.81 | -139.28 | -282.88 | -366.48 | -447.68 | -569.28 | -550.15 | -640.02 | -721.76 | -543.74 | -449.57 | -308.24 | -176.85 | -196.79 | -218.94 | -220.95 | -218.17 | -169.51 | -113.72 | -86.23 | -61.97 | -68.10 | -76.44 | -74.57 | -69.64 | -57.55 | -47.14 | -48.61 | -36.99 | -63.26 | -78.16 | -78.92 | -130.85 | -131.14 | -105.17 | -90.90 | - | -0.30 | -2.93 | - |
ROA % |
33.92 | 67.67 | 44.40 | -7.02 | -23.46 | -74.31 | -68.85 | -55.31 | -76.21 | -80.68 | -80.89 | -53.73 | -67.66 | -60.69 | -52.83 | -30.55 | -54.83 | -78.89 | -92.65 | -106.05 | -146.19 | -148.80 | -179.37 | -207.47 | -174.75 | -166.53 | -142.86 | -121.66 | -133.19 | -146.13 | -146.04 | -142.85 | -115.15 | -81.86 | -67.91 | -55.47 | -61.62 | -69.70 | -68.45 | -64.30 | -52.11 | -41.46 | -41.33 | -30.79 | -41.95 | -43.63 | -38.53 | -66.20 | -66.38 | -55.41 | -48.60 | - | -0.18 | -1.77 | - |
ROCE % |
75.31 | 138.50 | 23.10 | -175.62 | -210.41 | -314.87 | -234.61 | -104.22 | -131.55 | -124.08 | -114.13 | -67.59 | -84.09 | -73.27 | -62.83 | -35.97 | -193.58 | -334.68 | -416.94 | -339.49 | -482.31 | -467.52 | -190.98 | -131.30 | -178.45 | -82.78 | -309.70 | -130.87 | -200.37 | -222.71 | -224.96 | -153.18 | -166.79 | -110.91 | -83.08 | -44.83 | -66.61 | -74.77 | -72.84 | -46.19 | -57.79 | -47.63 | -49.25 | -37.42 | -66.39 | -83.75 | -95.38 | -205.26 | -205.57 | -176.92 | -151.82 | - | -0.31 | -3.09 | - |
Current Ratio |
1.5 | 1.8 | 1.8 | 1.9 | 2.0 | 1.2 | 1.2 | 1.4 | 1.9 | 2.0 | 2.3 | 2.7 | 4.2 | 4.9 | 5.3 | 5.9 | 5.9 | 5.9 | 5.9 | 1.3 | 1.3 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 3.2 | 3.2 | 3.2 | 3.2 | 2.9 | 2.9 | 2.9 | 2.9 | 9.5 | 9.5 | 9.5 | 9.5 | 13.1 | 13.1 | 13.1 | 13.1 | 6.0 | 6.0 | 6.0 | 6.0 | 3.4 | 3.4 | 3.4 | 3.4 | 3.0 | 2.5 | 2.5 | 2.5 |
DSO |
108.4 | 92.3 | 83.4 | - | 15.6 | 74.1 | 50.4 | - | 42.7 | 76.1 | 51.9 | - | 52.0 | 50.3 | 44.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
810.4 | 873.4 | 985.6 | - | 829.4 | 1371.7 | 1449.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
918.8 | 965.7 | 1069.1 | - | 845.0 | 1445.8 | 1499.6 | - | 42.7 | 76.1 | 51.9 | - | 52.0 | 50.3 | 44.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
918.8 | 965.7 | 1069.1 | - | 845.0 | 1445.8 | 1499.6 | - | 42.7 | 76.1 | 51.9 | - | 52.0 | 50.3 | 44.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency